BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6581851)

  • 1. Uterine rupture associated with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Can Anaesth Soc J; 1984 Jan; 31(1):80-2. PubMed ID: 6581851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rupture of the cervix during prostaglandin termination of pregnancy.
    El-Etriby EK; Daw E
    Postgrad Med J; 1981 Apr; 57(666):265-6. PubMed ID: 7291112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin.
    Phillips K; Berry C; Mathers AM
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):175-6. PubMed ID: 8730620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine rupture after induction of labour for intrauterine death using the prostaglandin E2 analogue sulprostone.
    Prasad RN; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):282-3. PubMed ID: 1445147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report.
    Wiener JJ; Evans AS
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1061-2. PubMed ID: 2252872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misdiagnosis of interstitial pregnancy followed by uterine cornual rupture during induced midtrimester abortion.
    Petersen KR; Larsen GK; Nørring K; Jensen FR
    Acta Obstet Gynecol Scand; 1992 May; 71(4):316-8. PubMed ID: 1322630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine rupture: a complication of midtrimester abortion.
    Friedman EA
    Prostaglandins; 1978 Jan; 15(1):187-91. PubMed ID: 625572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine rupture as a complication of second trimester abortion using intraamniotic prostaglandin E2 and augmentation with other oxytocic agents.
    McCarthy T; McQueen J
    Prostaglandins; 1980 Jun; 19(6):849-54. PubMed ID: 7384558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rupture of a healthy uterus in a prostaglandin-induced abortion in the second trimester].
    Larue L; Marpeau L; Percque M; Castiel J; Guettier X; Maghioracos P; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):269-72. PubMed ID: 2071873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 induced abortion with vaginal suppositories in a contraceptive diaphragm.
    Schulman H; Saldana L; Tsai T; Leibman T; Cunningham M; Randolph G
    Prostaglandins; 1974 Aug; 7(3):195-205. PubMed ID: 4415347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Anesth Analg; 1983 Nov; 62(11):1046. PubMed ID: 6578694
    [No Abstract]   [Full Text] [Related]  

  • 17. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Sandler RZ; Knutzen VK; Milano CM; Gleicher N
    Am J Obstet Gynecol; 1979 Jun; 134(3):348-9. PubMed ID: 453268
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine rupture with the use of a low-dose vaginal PGE2 tablet.
    Azem F; Jaffa A; Lessing JB; Peyser MR
    Acta Obstet Gynecol Scand; 1993 May; 72(4):316-7. PubMed ID: 8389523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine rupture with the use of vaginal prostaglandin E2 for induction of labor.
    Claman P; Carpenter RJ; Reiter A
    Am J Obstet Gynecol; 1984 Dec; 150(7):889-90. PubMed ID: 6594931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.